Functional regulation of OATP2B1 (SLCO2B1) by protein kinases

被引：0
|
作者：
Kock, K.
Grube, M.
Jedlitschky, G.
Ritter, C. A.
Kroemer, H. K.
机构：
[1] Ernst Moritz Arndt Univ Greifswald, Dept Pharmacol, Greifswald, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Dept Pharm, Greifswald, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2007年 / 375卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
4
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [21] Liver uptake of cefditoren is mediated by OATP1B1 and OATP2B1 in humans and Oatp1a1, Oatp1a4, and Oatp1b2 in rats
    Wang, Hepeng
    Sun, Pengyuan
    Wang, Changyuan
    Meng, Qiang
    Liu, Zhihao
    Huo, Xiaokui
    Sun, Huijun
    Ma, Xiaodong
    Peng, Jinyong
    Liu, Kexin
    RSC ADVANCES, 2017, 7 (48): : 30038 - 30048
  • [22] SLCO2B1 variants correlate with castration resistance
    Peter Sidaway
    Nature Reviews Urology, 2016, 13 (2) : 65 - 65
  • [23] Organic anion transporting polypeptide 2B1 (OATP2B1), an expanded substrate profile, does it align with OATP2B1's hypothesized function?
    Bednarczyk, Dallas
    Sanghvi, Menaka V.
    XENOBIOTICA, 2020, 50 (09) : 1128 - 1137
  • [24] SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria
    Sortica, Vinicius A.
    Lindenau, Juliana D.
    Cunha, Maristela G.
    Ohnishi, Maria Deise O.
    Ventura, Ana Maria R.
    Ribeiro-dos-Santos, A. ndrea K. C.
    Santos, Sidney E. B.
    Guimaraes, Luciano S. P.
    Hutz, Mara H.
    PHARMACOGENOMICS, 2017, 18 (15) : 1401 - 1411
  • [25] Frequencies of Single-Nucleotide Polymorphisms of SLCO1A2, SLCO1B3 and SLCO2B1 Genes in a Finnish Population
    Laitinen, Alli
    Niemi, Mikko
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 108 (01) : 9 - 13
  • [26] Comparison of genetic variations of the SLCO1B1, SLCO1B3, and SLCO2B1 genes among five ethnic groups
    Namgoong, Suhg
    Cheong, Hyun Sub
    Kim, Ji On
    Kim, Lyoung Hyo
    Na, Han Sung
    Koh, In Song
    Chung, Myeon Woo
    Shin, Hyoung Doo
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2015, 40 (03) : 692 - 697
  • [27] A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics
    Lehtisalo, Minna
    Taskinen, Suvi
    Tarkiainen, E. Katriina
    Neuvonen, Mikko
    Viinamaki, Jenni
    Paile-Hyvarinen, Maria
    Lilius, Tuomas O.
    Tapaninen, Tuija
    Backman, Janne T.
    Tornio, Aleksi
    Niemi, Mikko
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 242 - 252
  • [28] Influence of SLCO1B1 and SLCO2B1 Polymorphisms on Tacrolimus Pharmacokinetics and Clinical Efficacy and Safety.
    Alves, C.
    Felipe, C.
    Nishikawa, A.
    Salgado, P.
    Fajardo, C.
    Spinelli, G.
    Tedesco, H.
    Medina-Pestana, J.
    Hirata, M.
    Hirata, R.
    Rodrigues, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 503 - 503
  • [29] OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists
    Schaefer, Anima M.
    zu Schwabedissen, Henriette E. Meyer
    Bien-Moeller, Sandra
    Hubeny, Andrea
    Vogelgesang, Silke
    Oswald, Stefan
    Grube, Markus
    MOLECULAR PHARMACEUTICS, 2020, 17 (06) : 1987 - 1995
  • [30] Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
    Nies, Anne T.
    Niemi, Mikko
    Burk, Oliver
    Winter, Stefan
    Zanger, Ulrich M.
    Stieger, Bruno
    Schwab, Matthias
    Schaeffeler, Elke
    GENOME MEDICINE, 2013, 5
12345